Jason D. Goldman, M.D., from the Swedish Medical Center in Seattle, and colleagues compared organ utilization and recipient outcomes between SARS-CoV-2 NAT-positive and NAT-negative donors. Organs were recovered from 617 NAT-positive donors from all Organ Procurement and Transplantation Network regions and 53 of 57 organ procurement organizations from May 27, 2021, to Jan. 31, 2022.
Read more in Medical Xpress.
Among patients hospitalized with COVID-19, men were more likely than women to have CV complications, but the difference was not explained by lower rates of past CVD in women, researchers reported in BMJ Medicine. Read more in Healio.
Evusheld is no longer authorized for use to help prevent COVID-19 in the United States “until further notice,” due to a lack of protection against dominant variants, according to new guidance issued by the FDA.
In its updated guidance, the FDA limited the use of Evusheld (tixagevimab plus cilgavimab, AstraZeneca) to when the combined national frequency of variants that are not susceptible to the treatment is 90% or less. Read more in Healio.
As the world continues to grapple with effects of the COVID-19 pandemic, individuals around the globe are still dealing with symptoms of SARS-CoV-2 infection for months, even years, after their initial infection.
Post-acute sequelae of COVID-19, more commonly referred to as long COVID, are defined by the CDC as a wide range of new, returning or ongoing health issues that people experience after being infected with SARS-CoV-2, the virus that causes COVID-19.
Read more from Healio.
One year ago, Krystal Taylor-Vasquez spent the holidays in a bed in the intensive care unit, hoping for the double lung transplant that would save her life.
The Houston woman never expected her condition to deteriorate so quickly when she went to the Memorial Hermann emergency room with a severe COVID-19 infection in the summer of 2021.
Read the full story in the Houston Chronicle.
Report on 1st transplant in scleroderma patient predicts future success
The case of a person with scleroderma who successfully received a lung transplant from a donor who had tested positive for COVID-19 may predict positive outcomes for other patients, according to a recent report.
“To our knowledge this represents the first successful case of lung transplantation of donor lungs positive for COVID-19,” the researchers wrote. Read more in Scleroderma News.
Changes in gene expression patterns in the brain associated with natural aging also were observed in the brains of those with severe COVID-19, prompting researchers to emphasize the need for neurological follow-up in recovered individuals.
Read the full story in Healio.
Among patients previously hospitalized with COVID-19, researchers estimated that up to 11% had fibrotic patterning, according to a study published in American Journal of Respiratory and Critical Care Medicine. Read the full story in Healio.
Photon-counting detector CT found more subtle lung abnormalities that may indicate irreversible lung fibrosis in symptomatic patients following COVID-19 infection than conventional CT, according to a study published in Radiology.
Read more in Healio.
After months in intensive care, Cesar Franco became the first person in Britain to have the operation because of the virus
“When I woke up I was confused. I remembered the doctors in St George’s hospital deciding to intubate me. But when I woke up from the intubation, I’d been transferred to another hospital, St Thomas’, and was on a machine that was keeping me alive. I wondered how things had gotten so bad and how I’d gone from being just ill to being, you know, very close to dying.”
Read the story in The Guardian here.